Skip to main content
Log in

Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer

  • Original Papers
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

In intravesical therapy for superficial bladder carcinoma urothelial cells may, through the production of cytokines, contribute to the bacillus Calmette-Guérin (BCG)-induced local immunological reaction and associated antitumor efficacy. The aim of this study was to investigate such a role for the neutrophil-attracting cytokine interleukin-8 (IL-8). The appearance of IL-8 in patients' urine after BCG therapy was compared with BCG-induced IL-6 and IL-2 and the stability of IL-8 in urine was tested. Compared to IL-6 and IL-2, a rapid induction of IL-8 was observed, occurring after the first BCG instillation. Urinary IL-8 was highly stable, even after 24 h incubation at 37°C. The IL-8 concentration after the first instillation seemed to be associated with subsequent development of an immune response. Consequently, IL-8 seems an attractive candidate for investigation of its prognostic value for a clinical response to BCG therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Agace WW, Hedges SR, Ceska M, Svanborg C (1993) Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 92:780

    Google Scholar 

  2. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045

    Google Scholar 

  3. Bettex-Galland M, Studer UE, Walz A, Dewald B, Baggiolini M (1991) Neutrophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Guérin administration. Eur Urol 19:171

    Google Scholar 

  4. Cassatella MA (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21

    Google Scholar 

  5. De Boer EC, De Jong WH, Van Der Meijden APM, Steerenberg PA, Witjes F, Vegt PDJ, Debruyne FMJ, Ruitenberg EJ (1991) Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer: A flow cytofluorometric analysis. Urol Res 1:45

    Google Scholar 

  6. De Boer EC, De Reijke TM, Schamhart DHJ, Vos PCN, Kurth K-H (1993) Increased urinary albumin indicating urothelial leakage following intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Urol Res 21:423

    Google Scholar 

  7. De Boer EC, Schamhart DHJ, Somogyi L, Kurth K-H (1995) IL-8 and onset of BCG-induced immune response. Urol Res 23:250 (P22)

    Google Scholar 

  8. De Reijke ThM. Vos PCN, De Boer EC, Bevers RFM, De Muinck Keizer WH, Kurth K-H, Schamhart DHJ (1993) Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guérin (BCG). Urol Res 21:349

    Google Scholar 

  9. De Reijke ThM, De Boer EC, Kurth K-H, Schamhart DHJ (1996) Urinary cytokines during intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer: processing, stability and prognostic value. J Urol 155:477

    Google Scholar 

  10. Hedges S, Svensson M, Svanborg C (1992) Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 60:1295

    Google Scholar 

  11. Jackson AM, James K (1994) Understanding the most successful immunotherapy for cancer. The Immunologist 2:208

    Google Scholar 

  12. Ratliff TL (1989) Mechanisms of action of intravesical BCG for bladder cancer. Progr Clin Biol Res 310:107

    Google Scholar 

  13. Thalmann G, Dewald B, Baggiolini M, Studer U (1993) Kinetics and stability of interleukin-8 (IL-8) in the urine after transurethral resection (TUR-B) and after intravesical instillations with bacillus Calmette-Guérin (BCG) in patients with superficial bladder cancer. J Urol 149:337A

    Google Scholar 

  14. Van Der Sloot E, Kuster S, Böhle A, Braun J, Wood WG (1992) Towards an understanding of the mode of action of bacillus Calmette-Guérin therapy in bladder cancer treatment, especially with regard to the role of fibronectin. Eur J Clin Chem Clin Biochem 30:503

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Boer, E.C., Somogyi, L., de Ruiter, G.J.W. et al. Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer. Urol. Res. 25, 31–34 (1997). https://doi.org/10.1007/BF00941903

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00941903

Key words

Navigation